Indivior to Pay $600M to Settle Claims of Deceptive Marketing of Opioid Treatment

Indivior Plc has agreed to pay $600 million and have a subsidiary plead guilty to a felony charge to resolve U.S. allegations that it engaged in an illegal scheme to boost prescriptions of its opioid addiction treatment Suboxone. The U.S. …

from News – Insurance Journal